BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 19765110)

  • 21. The C-terminus of Apc does not influence intestinal adenoma development or progression.
    Lewis A; Davis H; Deheragoda M; Pollard P; Nye E; Jeffery R; Segditsas S; East P; Poulsom R; Stamp G; Wright N; Tomlinson I
    J Pathol; 2012 Jan; 226(1):73-83. PubMed ID: 22009253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of R-Spondin 1 in Apc
    Lähde M; Heino S; Högström J; Kaijalainen S; Anisimov A; Flanagan D; Kallio P; Leppänen VM; Ristimäki A; Ritvos O; Wu K; Tammela T; Hodder M; Sansom OJ; Alitalo K
    Gastroenterology; 2021 Jan; 160(1):245-259. PubMed ID: 32941878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cooperation between the thyroid hormone receptor TRalpha1 and the WNT pathway in the induction of intestinal tumorigenesis.
    Kress E; Skah S; Sirakov M; Nadjar J; Gadot N; Scoazec JY; Samarut J; Plateroti M
    Gastroenterology; 2010 May; 138(5):1863-74. PubMed ID: 20114049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A limited role for p53 in modulating the immediate phenotype of Apc loss in the intestine.
    Reed KR; Meniel VS; Marsh V; Cole A; Sansom OJ; Clarke AR
    BMC Cancer; 2008 Jun; 8():162. PubMed ID: 18533991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin D receptor deficiency enhances Wnt/β-catenin signaling and tumor burden in colon cancer.
    Larriba MJ; Ordóñez-Morán P; Chicote I; Martín-Fernández G; Puig I; Muñoz A; Pálmer HG
    PLoS One; 2011; 6(8):e23524. PubMed ID: 21858154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in FAP mouse models.
    Mieszczanek J; van Tienen LM; Ibrahim AEK; Winton DJ; Bienz M
    Nat Commun; 2019 Feb; 10(1):724. PubMed ID: 30760710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A role for the epidermal growth factor receptor signaling in development of intestinal serrated polyps in mice and humans.
    Bongers G; Muniz LR; Pacer ME; Iuga AC; Thirunarayanan N; Slinger E; Smit MJ; Reddy EP; Mayer L; Furtado GC; Harpaz N; Lira SA
    Gastroenterology; 2012 Sep; 143(3):730-740. PubMed ID: 22643351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PTEN loss and activation of K-RAS and β-catenin cooperate to accelerate prostate tumourigenesis.
    Jefferies MT; Cox AC; Shorning BY; Meniel V; Griffiths D; Kynaston HG; Smalley MJ; Clarke AR
    J Pathol; 2017 Dec; 243(4):442-456. PubMed ID: 29134654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The absence of LPA receptor 2 reduces the tumorigenesis by ApcMin mutation in the intestine.
    Lin S; Lee SJ; Shim H; Chun J; Yun CC
    Am J Physiol Gastrointest Liver Physiol; 2010 Nov; 299(5):G1128-38. PubMed ID: 20724530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apc Restoration Promotes Cellular Differentiation and Reestablishes Crypt Homeostasis in Colorectal Cancer.
    Dow LE; O'Rourke KP; Simon J; Tschaharganeh DF; van Es JH; Clevers H; Lowe SW
    Cell; 2015 Jun; 161(7):1539-1552. PubMed ID: 26091037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of Rassf1a cooperates with Apc(Min) to accelerate intestinal tumourigenesis.
    van der Weyden L; Arends MJ; Dovey OM; Harrison HL; Lefebvre G; Conte N; Gergely FV; Bradley A; Adams DJ
    Oncogene; 2008 Jul; 27(32):4503-8. PubMed ID: 18391979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Putative direct and indirect Wnt targets identified through consistent gene expression changes in APC-mutant intestinal adenomas from humans and mice.
    Segditsas S; Sieber O; Deheragoda M; East P; Rowan A; Jeffery R; Nye E; Clark S; Spencer-Dene B; Stamp G; Poulsom R; Suraweera N; Silver A; Ilyas M; Tomlinson I
    Hum Mol Genet; 2008 Dec; 17(24):3864-75. PubMed ID: 18782851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. K-ras exon 4A has a tumour suppressor effect on carcinogen-induced murine colonic adenoma formation.
    Luo F; Ye H; Hamoudi R; Dong G; Zhang W; Patek CE; Poulogiannis G; Arends MJ
    J Pathol; 2010 Apr; 220(5):542-50. PubMed ID: 20087880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutational activation of the RAS-RAF-MAPK and the Wnt pathway in small intestinal adenocarcinomas.
    Bläker H; Helmchen B; Bönisch A; Aulmann S; Penzel R; Otto HF; Rieker RJ
    Scand J Gastroenterol; 2004 Aug; 39(8):748-53. PubMed ID: 15513360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The adenomatous polyposis coli-associated exchange factors Asef and Asef2 are required for adenoma formation in Apc(Min/+)mice.
    Kawasaki Y; Tsuji S; Muroya K; Furukawa S; Shibata Y; Okuno M; Ohwada S; Akiyama T
    EMBO Rep; 2009 Dec; 10(12):1355-62. PubMed ID: 19893577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer stemness in Apc- vs. Apc/KRAS-driven intestinal tumorigenesis.
    Ghazvini M; Sonneveld P; Kremer A; Franken P; Sacchetti A; Atlasi Y; Roth S; Joosten R; Smits R; Fodde R
    PLoS One; 2013; 8(9):e73872. PubMed ID: 24069241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A targeted constitutive mutation in the APC tumor suppressor gene underlies mammary but not intestinal tumorigenesis.
    Gaspar C; Franken P; Molenaar L; Breukel C; van der Valk M; Smits R; Fodde R
    PLoS Genet; 2009 Jul; 5(7):e1000547. PubMed ID: 19578404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined Mutation of
    Sakai E; Nakayama M; Oshima H; Kouyama Y; Niida A; Fujii S; Ochiai A; Nakayama KI; Mimori K; Suzuki Y; Hong CP; Ock CY; Kim SJ; Oshima M
    Cancer Res; 2018 Mar; 78(5):1334-1346. PubMed ID: 29282223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway.
    Wielenga VJ; Smits R; Korinek V; Smit L; Kielman M; Fodde R; Clevers H; Pals ST
    Am J Pathol; 1999 Feb; 154(2):515-23. PubMed ID: 10027409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. WNT signaling controls expression of pro-apoptotic BOK and BAX in intestinal cancer.
    Zeilstra J; Joosten SP; Wensveen FM; Dessing MC; Schütze DM; Eldering E; Spaargaren M; Pals ST
    Biochem Biophys Res Commun; 2011 Mar; 406(1):1-6. PubMed ID: 21184732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.